Last reviewed · How we verify

NCT05150093

Deep Brain Stimulation in Laryngeal Dystonia and Voice Tremor

Recruiting now NA Last updated 2 December 2025
What this trial tests

NA trial testing Deep Brain Stimulation in Laryngeal Dystonia in 120 participants. Currently enrolling.

Timeline
21 June 2022
Primary endpoint
31 August 2027
31 August 2027

Quick facts

Lead sponsorMassachusetts Eye and Ear Infirmary
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment120
Start date21 June 2022
Primary completion31 August 2027
Estimated completion31 August 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Massachusetts Eye and Ear Infirmary — full company profile →

Who can join

Adults 18 to 80, any sex, with Laryngeal Dystonia or Spasmodic Dysphonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goals of this project are 1) to determine the incidence of neurological voice disorders in patients with dystonia and essential tremor undergoing deep brain stimulation (DBS), 2) investigate the neuroimaging and intracranial neurophysiology correlates of voice dysfunction in these subjects, and subsequently 3) determine the effects of DBS on voice function.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
    Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991

Verify or expand the search:

Other trials of Deep Brain Stimulation

Trials testing the same drug.

Other recruiting trials for Laryngeal Dystonia

Currently open trials in the same condition.

Other Massachusetts Eye and Ear Infirmary trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing